Brain News and Research

RSS

The human brain is the center of the human nervous system and is a highly complex organ. Enclosed in the cranium, it has the same general structure as the brains of other mammals, but is over three times as large as the brain of a typical mammal with an equivalent body size.

MicroStockProfit.com: CUR reports net loss of $5,096,983 for third-quarter of 2009

MicroStockProfit.com announces an investment report featuring Neuralstem Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

21 Apr 2010

Posit Science challenges BBC study on cognitive training programs

Posit Science, the leader in clinically proven brain fitness programs, contests the interpretation and methodology used in a British Broadcasting Corporation-sponsored study published in the journal Nature.

21 Apr 2010

Receiving cochlear implant before 18 months of age improves child's ability to hear: Study

Receiving a cochlear implant before 18 months of age dramatically improves a deaf child's ability to hear, understand and, eventually, speak, according to a multicenter study led by scientists at Johns Hopkins.

21 Apr 2010

Immunomedics reports study results of antibody-SN-38 conjugates for targeted cancer chemotherapy

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, reported today at the 101st Annual Meeting of the American Association for Cancer Research (AACR) results from two studies aimed at improving the design of antibody-SN-38 conjugates for targeted cancer chemotherapy.

21 Apr 2010

Researchers discover subunits of GABAB receptors in central nervous system

In the latest issue of the renowned scientific journal "Nature" researchers from the universities of Freiburg and Basel report on their discovery of previously unknown subunits of the GABAB receptors in the central nervous system. GABAB receptors are transmembrane proteins in nerve cells which are of fundamental significance for the functioning of the brain and have great therapeutical and pharmaceutical importance.

21 Apr 2010

Children with developmental regression at increased risk for more severe autism: Study

Kennedy Krieger Institute announced today new study results showing that when and how autism symptoms appear in the first three years of life has vital implications to a child's developmental, diagnostic, and educational outcomes.

21 Apr 2010

miRNAs may generate new insights on cancer and possible future treatments

Scientists are methodically unlocking the biological processes that lead to cancer, and recent discoveries with microRNAs (miRNAs) are revolutionizing their understanding and leading to clinical trials of potentially effective treatments.

21 Apr 2010

CSTE receives $1M gift from NFL to research long-term effects of repetitive brain trauma in football players

The National Football League (NFL) will give a $1 million unrestricted gift to the Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine to support the Center's research.

21 Apr 2010

Mental exercises: do they work?

It has been long believed and aggressively drilled into our brains that computer programs and games that are targeted towards memory enhancement improve memory, mental health, intelligence and prevent age related memory loss and dementia. In a new study such claims have been found to be empty.

21 Apr 2010

ABRAXANE-bevacizumab combination therapy may exhibit potential in treatment of triple-negative breast cancers

Abraxis BioScience, Inc., a fully integrated biotechnology company, announced study results today that demonstrate a regimen of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) given in combination with bevacizumab (Avastin®) may have potential in the treatment of triple-negative breast cancers.

21 Apr 2010

Obesity related FTO gene linked to Alzheimer’s disease.

If you are an American of European origin and carry the FTO gene which causes obesity, you have a much higher risk of developing Alzheimer’s disease. A recent study conducted at the University of California, Los Angeles claimed that 'A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in healthy elderly'.

21 Apr 2010

Researchers identify potential drug target for treatment of Alzheimer's disease

Researchers at the University of Illinois have identified a potential drug target for the treatment of Alzheimer's disease: a receptor that is embedded in the membrane of neurons and other cells.

21 Apr 2010

CytRx' bafetinib receives EMEA COMP positive opinion for treatment of CML

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that bafetinib (formerly known as INNO-406) has received official notification from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA) that a positive opinion was made regarding the application for orphan medicinal product for the treatment of chronic myeloid leukemia (CML).

20 Apr 2010

TYSABRI drives Biogen Idec's first-quarter revenues of $1.1 billion

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its first quarter 2010 results.

20 Apr 2010

Acorda Therapeutics to initiate Phase 1 clinical trial of GGF2 for heart failure in mid-2010

Acorda Therapeutics, Inc. today announced plans to initiate a Phase 1 single-dose clinical trial of the Company's compound, Glial Growth Factor 2 (GGF2), in patients with heart failure in mid-2010, based on an IND filed with the U.S. Food and Drug Administration (FDA) on March 19, 2010. GGF2 has been shown to protect heart muscle and restore cardiac function in preclinical models of heart failure, myocardial infarction and cardiotoxicity.

20 Apr 2010

Affymetrix introduces new service for obtaining allele-specific copy number data from FFPE samples

Affymetrix, Inc. today announced the launch of the Affymetrix® MIP Copy Number Service, designed for cancer researchers using challenging FFPE samples. With the MIP Copy Number Service, scientists can now obtain high-quality allele-specific copy number data from FFPE samples. The service is available for research use only exclusively through the Affymetrix® Research Services Laboratory (ARSL).

20 Apr 2010

Teva Pharmaceutical Industries presents ADAGIO study results at AAN Annual Meeting

Teva Pharmaceutical Industries Ltd. today announced results from the placebo group analyses of the ADAGIO study that were presented at the 62nd Annual Meeting of the American Academy of Neurology. The ADAGIO study stands out from other Parkinson's disease trials as it is the largest clinical study conducted in patients who were still in the very early stages of their disease course (average time from PD diagnosis of 4.5 months).

20 Apr 2010

New technique that involves voice analysis to diagnose Parkinson's disease developed

A new technique assisting in early diagnosis of Parkinson's disease has been developed by Prof. Shimon Sapir of the Department of Communication Sciences and Disorders at the University of Haifa. This technique involves analysis of voice and articulation. The research was carried out alongside U.S. scientists and with funding from the National Institutes of Health, and results have been published in the Journal of Speech, Language, and Hearing Research.

20 Apr 2010

Clinical success of LOW LEVEL LASER THERAPY to treat FMS reported in Fibromyalgia Aware

Fibromyalgia is a condition in which the brain processes pain in an abnormal way, resulting in chronic, widespread muscular-skeletal pain and chronic fatigue. This condition effects millions of Americans and has been poorly understood and under diagnosed, resulting in billions of dollars in cost to our health care system.

20 Apr 2010

Migraine attacks leading to a Chinese accent in a British woman

In a bizarre incident a British woman after repeated attacks of migraine headache has started speaking with a Chinese accent. Sarah Colwill, 35, according to experts is suffering from a condition known as Foreign Accent Syndrome (FAS).

20 Apr 2010

Brain News and Research

Further Reading

MicroStockProfit.com: CUR reports net loss of $5,096,983 for third-quarter of 2009

Posit Science challenges BBC study on cognitive training programs

Receiving cochlear implant before 18 months of age improves child's ability to hear: Study

Immunomedics reports study results of antibody-SN-38 conjugates for targeted cancer chemotherapy

Researchers discover subunits of GABAB receptors in central nervous system

Children with developmental regression at increased risk for more severe autism: Study

miRNAs may generate new insights on cancer and possible future treatments

CSTE receives $1M gift from NFL to research long-term effects of repetitive brain trauma in football players

Mental exercises: do they work?

ABRAXANE-bevacizumab combination therapy may exhibit potential in treatment of triple-negative breast cancers

Obesity related FTO gene linked to Alzheimer’s disease.

Researchers identify potential drug target for treatment of Alzheimer's disease

CytRx' bafetinib receives EMEA COMP positive opinion for treatment of CML

TYSABRI drives Biogen Idec's first-quarter revenues of $1.1 billion

Acorda Therapeutics to initiate Phase 1 clinical trial of GGF2 for heart failure in mid-2010

Affymetrix introduces new service for obtaining allele-specific copy number data from FFPE samples

Teva Pharmaceutical Industries presents ADAGIO study results at AAN Annual Meeting

New technique that involves voice analysis to diagnose Parkinson's disease developed

Clinical success of LOW LEVEL LASER THERAPY to treat FMS reported in Fibromyalgia Aware

Migraine attacks leading to a Chinese accent in a British woman

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News